6QC vs FUP: Side-by-Side Comparison
Compare TOWA PHARMA. CO. (6QC) and Fuji Pharma Co. Ltd (FUP) side by side: market cap EUR 994.40M vs EUR 279.48M, P/E 34.8 vs 19.8. Financials, growth and model signals on Bullrun.
| Metric | 6QC | FUP |
|---|---|---|
| Company | TOWA PHARMA. CO. | Fuji Pharma Co. Ltd |
| Country / Exchange | Japan · F | Japan · F |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic |
| Market cap | EUR 994.40M | EUR 279.48M |
| P/E ratio | 34.8 | 19.8 |
| Dividend yield | 2.25% | 2.55% |
| Valuation model | 28.7% overvalued | 7.7% overvalued |
| Revenue (FY2025) | EUR 259.59B | EUR 51.68B |
| Revenue growth YoY | +13.9% | +12.0% |
| Net income | EUR 18.99B | EUR 3.00B |
| Gross margin | 36.5% | 40.2% |
| Diluted EPS | 385.71 | 122.94 |